Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3660-3663

  Guldberg, Per ^a   Thor Straten, Per ^a   Birck, Anette ^a,b   Ahrenkiel, Vibeke ^a   Kirkin, Alexei F ^a   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 10Q; CYTOSKELETON; GENE DELETION; GENE DISRUPTION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; RNA SPLICING; TARGET CELL;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 10; EXONS; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030777104     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Koh, H. K. Cutaneous melanoma. N. Engl. J. Med., 325: 171-182, 1991.
2. Albino, A. P. Genes involved in melanoma susceptibility and progression. Curr. Opin. Oncol., 7: 162-169, 1995.
3. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res., 54: 3111-3114, 1994.
4. Isshiki, K., Elder, D. E., Guerry, D., and Linnenbach, A. J. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer, 8: 178-184, 1993.
5. Healy, E., Rehman, I., Angus, B., and Rees, J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer, 12: 152-156, 1995.
6. Walker, G. J., Palmer, J. M., Walters, M. K., and Hayward, N. K. A genetic model of melanoma tumortgenesis based on allelic losses. Genes Chromosomes Cancer, 12: 134-141, 1995.
7. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 thai is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
8. Li. J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
9. Kirkin, A. F., Petersen, T. R., Olsen, A. C., Li, L., thor Straten, P., and Zeuthen, J. Generation of human melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother., 41: 71-81, 1995.
10. thor Straten, P., Kirkin, A. F., Seremet, T., and Zeuthen, J. Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines. Int. J. Cancer, 70: 582-586, 1997.
11. Guldberg, P., Romano, V., Ceratto, N., Bosco, P., Ciuna, M., Indelicato, A., Mollica, F., Meli, C., Giovannini, M., Riva, E., Biasucci, G., Henriksen, K. F., and Güttler, F. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum. Mol. Genet., 2: 1703-1707, 1993.
12. Myers, R. M., Maniatis, T., and Lerman, L. S. Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol., 155: 501-527, 1987.
13. Guldberg, P., Nedergaard, T., Nielsen, H. J., Olsen, A. C., Ahrenkiel, V., and Zeuthen, J. Single-step DGGE-based mutation scanning of the p5J gene: application to genetic diagnosis of colorectal cancer. Hum. Mutat., 9: 348-355, 1997.
14. Lerman, L. S., and Silverstein, K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol., 155: 482-501, 1987.
15. Sheffield, V. C., Cox, D. R., Lerman, L. S., and Myers, R. M. Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction in improved detection of single-base changes. Proc. Natl. Acad. Sci. USA, 86: 232-236, 1989.
16. Cremonesi, L., Firpo, S., Ferrari, M., Righetti, P. G., and Gelfi, C. Double-gradient UGGE for optimized detection of DNA point mutations. Biotechniques, 22: 326-330, 1997.
17. Krawczak, M., Reiss, J., and Cooper, D. N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet., 90: 41-54, 1992.
18. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
19. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S. I. I. I., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
20. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
21. Pollock, P. M., Yu, F., Qiu, L., Parsons, P. G., and Hayward, N. K. Evidence for u.v, induction of CDKN2 mutations in melanoma cell lines. Oncogene, 11: 663-668, 1995.
22. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J., and Bartek, J. The p16-cyclin D/Cdk4-pRB pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res., 56: 5475-5483, 1996.
23. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
24. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F., Anderson, D. E., Bergman, W., Frants, R., Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., Meyer, L. J., Youl, P., Zone, J. J., Skolnick, M. H., and Cannon-Albright, L. A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 22-26, 1994.
25. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., and Louis, D. N. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.